JENNIFER KRAMPERT: Open Payments
NPI 1194461400 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 27 payments from 12 companies in 2025. Trend: 2023 $400 · 2024 $539 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 6 | $171 |
| Novartis Pharmaceuticals Corporation | 5 | $77 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $59 |
| Boston Scientific Corporation | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| PFIZER INC. | 2 | $45 |
| Abbott Laboratories | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| CVRx, Inc. | 1 | $24 |
| Biosense Webster, Inc. | 1 | $19 |
Products named: LEQVIO, LifeVest, Kerendia, VYNDAQEL, General - EP, SHINGRIX, VIEWMATE, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
